Summary

Global Functional Near Infrared Optical Brain Imaging Market is valued approximately at USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2021-2027. Blood flow in the front part of the brain is measured using functional near-infrared (fNIR) optical brain imaging, which is subjected to near-infrared light for supervision. As patients go about their daily tasks, fNIR devices enable real-time monitoring of tissue oxygenation in the brain. The market is driven by emerging trends in product and rising prevalence of neurological disorders. For instance, PerkinElmer Inc.'s COX 2 probe, a targeted NIR dye, detects cyclooxygenase-2, which is generated in early-stage cancer. Oncology medicines and diagnostic devices are developed more quickly using these dyes. Furthermore, increasing expenditure on healthcare further boost the market growth. According to the American Hospital Association, there are about 5,198 hospitals in the United States. According to the Centers for Medicare & Medicaid Services, spending on healthcare increased by 4.6 percent in 2018, with an average of USD 11,172 spent per person. However, reimbursement challenges may impede market growth over the forecast period of 2021-2027.

North America dominated the market for near infrared imaging total revenue, and is anticipated to expand the market over the forecast period. Consumers' high disposable income, as well as the rapid adoption of technologically advanced medical gadgets and diagnostic procedures, have all contributed to this increase. The market in the United States is projected to grow as a result of a significant number of cancer cases recorded in the country. According to the American Cancer Society, 1685,210 new cancer cases were discovered in the United States in 2016.


Major market player included in this report are:
NIRx Medical Technologies LLC
Artinis Medical Systems
Thermo Fisher Scientific, Inc.
Hitachi Ltd.
Soterix Medical Inc.
Shimadzu Corporation
Spectratech Inc
Gowerlabs Ltd
Biopac Systems Inc.
Cephalon




The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application:
Parkinson's Disease
Epilepsy
Dementia
Traumatic Brain Injury
Sleep Disorders
Other Application Types
By End user:
Hospitals
Diagnostic Centers
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Functional Near Infrared Optical Brain Imaging Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors